Results 151 to 160 of about 17,658 (183)
Some of the next articles are maybe not open access.
Aflibercept for the treatment of neovascular age-related macular degeneration
Drugs of Today, 2012Age-related macular degeneration (AMD) can have devastating effects on vision, especially in its neovascular form. In the last decade, the use of intravitreal pharmacotherapy targeted to vascular endothelial growth factor (VEGF) has significantly improved the visual outcomes in patients with neovascular AMD.
E A, Verner-Cole, S J, Davis, A K, Lauer
openaire +2 more sources
Innovative therapies for neovascular age-related macular degeneration
Expert Opinion on Pharmacotherapy, 2019Introduction: Investigational anti-VEGF treatments for neovascular age-related macular degeneration (nAMD) aim to improve visual outcomes and reduce treatment burden; these include long-acting agents, combination strategies, topical agents, sustained-release, and genetic therapies.
Hasenin, Al-Khersan +3 more
openaire +2 more sources
Guidance for the treatment of neovascular age-related macular degeneration
Acta Ophthalmologica Scandinavica, 2007Neovascular age-related macular degeneration is becoming an increasing socio-medical problem as the proportion of the aged population is continuously increasing. However, new insights in the pathogenesis of the disease offer the opportunity to develop targeted therapies that attack the disease process more successfully than ever.
Schmidt Erfurth UM +9 more
openaire +2 more sources
New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
Journal of Clinical Medicine, 2021Veeral Sheth
exaly
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
Ophthalmology, 2020Ramin Tadayoni +2 more
exaly
Macular atrophy development in neovascular age-related macular degeneration
European Journal of Ophthalmology, 2020Dan Călugăru, Mihai Călugăru
openaire +2 more sources
Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
International Journal of Molecular Sciences, 2020Giovanni Staurenghi +2 more
exaly